ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CALT Calliditas Therapeutics AB

39.49
-1.92 (-4.64%)
Jun 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Calliditas Therapeutics AB CALT NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
-1.92 -4.64% 39.49 15:00:06
Open Price Low Price High Price Close Price Previous Close
39.60 39.22 39.67 39.49 41.41
more quote information »

Recent News

Date Time Source Heading
5/30/202415:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/30/202413:20PRNUSCalliditas partner STADA receives positive CHMP opinion..
5/30/202413:18PRNUSCalliditas partner STADA receives positive CHMP opinion..
5/28/202407:46PRNUSCalliditas Therapeutics Presents Data at the 61st European..
5/28/202407:36PRNUSCalliditas Therapeutics Presents Data at the 61st European..
5/28/202407:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/28/202407:09EDGAR2Form SC14D9C - Written communication relating to third party..
5/28/202402:17PRNUSStatement by the Board of Directors of Calliditas..
5/28/202402:14PRNUSStatement by the Board of Directors of Calliditas..
5/23/202415:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/23/202400:55PRNUSCalliditas Q1 report, January - March 2024
5/23/202400:52PRNUSCalliditas Q1 report, January - March 2024
5/16/202415:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
5/16/202401:45PRNUSInvitation to the presentation of Calliditas´s interim..
5/16/202401:43PRNUSInvitation to the presentation of Calliditas´s interim..
5/15/202407:30PRNUSCalliditas Therapeutics to Present Data at ERA 2024 May 23 -..
5/15/202407:24PRNUSCalliditas Therapeutics to Present Data at ERA 2024 May 23 -..
5/15/202406:36PRNUSNotice of annual general meeting of Calliditas Therapeutics..
5/15/202406:30PRNUSNotice of annual general meeting of Calliditas Therapeutics..
5/14/202406:52PRNUSCalliditas' Partner Everest Medicines Starts Commercial..
5/14/202406:35PRNUSCalliditas' Partner Everest Medicines Starts Commercial..
5/06/202401:16PRNUSCalliditas announces positive topline results of Phase 2..
5/06/202401:11PRNUSCalliditas announces positive topline results of Phase 2..
4/24/202412:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
4/24/202412:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
4/24/202402:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
4/24/202402:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
4/18/202406:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
4/18/202406:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
4/09/202406:24PRNUSCalliditas Therapeutics to Attend Conferences in April
4/09/202406:22PRNUSCalliditas Therapeutics to Attend Conferences in April
4/08/202407:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
4/08/202407:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
4/08/202402:24PRNUSCalliditas receives notice of allowance for United States..
4/08/202402:22PRNUSCalliditas receives notice of allowance for United States..
3/11/202420:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
3/06/202401:38PRNUSCalliditas announces an additional seven year orphan drug..
3/06/202401:34PRNUSCalliditas announces an additional seven year orphan drug..
3/01/202406:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
3/01/202406:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
2/21/202400:45PRNUSCalliditas Year-end report, January - December 2023
2/21/202400:43PRNUSCalliditas Year-end report, January - December 2023
2/14/202400:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
2/14/202400:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
2/13/202410:28PRNUSCalliditas provides patent update
2/13/202410:26PRNUSCalliditas provides patent update
1/08/202407:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/08/202401:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
1/08/202401:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
1/07/202410:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..

Your Recent History

Delayed Upgrade Clock